Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Military briefing: Ukraine seeks way to break Russia’s Black Sea blockade
    • China cuts mortgage lending rate by record as lockdowns hit economy
    • EU blocks UK scientists from €95bn Horizon research programme
    • BoE chief economist warns on UK’s strong ‘inflationary momentum’
    • Italy imports more Russian oil to feed refineries
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Wall Street stocks sink into bear market as growth concerns mount
    • Sexual misconduct case rocks $47bn asset manager GoldenTree
    • Twitter deal leaves Elon Musk with no easy way out
    • How the Colombia election could change Latin America
    • Donald Trump risks coming up short in Georgia grudge match: ‘People are moving on’
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Sexual misconduct case rocks $47bn asset manager GoldenTree
    • THG rejects £2bn bid as Candy weighs up online retailer
    • Mercedes axes cheaper models in bid for luxury brand status
    • HSBC banker draws fire after accusing policymakers of climate change hyperbole
    • Why on earth did Warren Buffett swap Wells Fargo for Citigroup?
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Live news: Deere raises profit forecast as strong demand offsets supply chain constraints
    • Wall Street stocks sink into bear market as growth concerns mount
    • What are investors supposed to trust in now?
    • The Goldilocks crisis may have arrived for crypto
    • Live news updates from May 19: Over 8,000 civilians killed or injured in Ukraine war, THG rejects £2bn bid
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Why buying a flat might not be such a good idea
    • An abandoned subway is a tragedy for New York
    • There is a moral case against crypto
    • What are investors supposed to trust in now?
    • The Goldilocks crisis may have arrived for crypto
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • As a longtime trailing spouse, how do I get back into full-time work?
    • Are universities suffering from management bloat?
    • Spreadsheets are now cool, thanks to TikTok
    • “Oleg, it’s obviously great news that you have not been sanctioned”
    • Bonuses are outdated in the age of knowledge work
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Smart, co-operative, emotional: what cutting-edge science tells us about pigs
    • Why buying a flat might not be such a good idea
    • Ukraine’s ex-president Petro Poroshenko: ‘The army is like my child, and I am very proud’
    • What are investors supposed to trust in now?
    • The truckers who keep our world moving
  • How to Spend It
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Medical science

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 20 May, 2022
    Russell Foster
    Calculating the real cost of the graveyard shift

    Aligning work and healthcare with the body’s circadian cycles could bring revolutionary health benefits

  • Friday, 20 May, 2022
    Chinese economy
    China cuts mortgage lending rate by record as lockdowns hit economy

    Five-year loan prime rate slashed by most since before pandemic as government steps up stimulus

  • Friday, 20 May, 2022
    News in-depthNorth Korea
    Unvaccinated and unprepared, North Korea faces Covid catastrophe

    Pyongyang’s gamble on extreme isolation has unravelled as Omicron sweeps the country

  • Thursday, 19 May, 2022
    UK politics & policy
    UK’s autumn Covid booster campaign could exclude most Britons

    JCVI’s provisional guidance limits top-up jabs to over-65s, frontline health workers and vulnerable younger people

  • Thursday, 19 May, 2022
    Disease control and prevention
    US records first monkeypox case since virus reported in Europe

    Infections investigated in 7 countries as scientists explore possibility of community transmission

  • Wednesday, 18 May, 2022
    Coronavirus pandemic
    How can Covid-19 affect the human brain?

    Scientists are trying to understand the cause of neurological effects and whether symptoms will be long-lasting

  • Monday, 16 May, 2022
    News in-depthCoronavirus pandemic
    Residents and guards suffer on Beijing’s zero-Covid front line

    China’s strict policy puts citizens at mercy of unpredictable isolation orders as security camps outside

  • Thursday, 12 May, 2022
    North Korea
    Kim Jong Un orders lockdowns as North Korea confirms first Covid cases

    Isolated country has not vaccinated population, stoking worries about potential damage of outbreak

  • Tuesday, 10 May, 2022
    Anjana Ahuja
    Clues but few answers in the childhood hepatitis mystery

    Lockdowns, adenoviruses, Covid and exposure to dogs have all been blamed for new cases around the world

  • Tuesday, 10 May, 2022
    Coronavirus pandemic
    WHO chief warns that China’s zero-Covid strategy is not sustainable

    New modelling underscores country’s vulnerability because of faltering vaccination drive

  • Thursday, 5 May, 2022
    Coronavirus pandemic
    Coronavirus far deadlier than official count, WHO estimate suggests

    Health body says 15mn people died by the end of 2021, nearly three times official death toll

  • Thursday, 5 May, 2022
    Coronavirus pandemic
    ‘Stay vigilant’: no let-up in North Korea’s two-year Covid lockout

    Pyongyang claims to have avoided a big outbreak but experts warn its luck will eventually run out

  • Wednesday, 4 May, 2022
    Coronavirus treatment
    UK accused of leaving Covid immunocompromised ‘out to dry’

    Vulnerable people feel they are forgotten because of government’s ‘living with Covid’ strategy

  • Tuesday, 3 May, 2022
    Anjana Ahuja
    Beware malaria risk from efforts to cool the planet

    The supposedly magic fix of solar geoengineering may have a dangerously uneven impact across the world

  • Sunday, 1 May, 2022
    Coronavirus pandemic
    Bill Gates calls for global surveillance team to spot pandemic threats

    The philanthropist urges world leaders to increase spending to improve preparedness for health threats

  • Friday, 29 April, 2022
    Disease control and prevention
    Scientists puzzle over Covid pandemic link to child hepatitis cases

    Experts are racing to find the cause of an unexplained illness diagnosed in nearly 200 youngsters

  • Thursday, 28 April, 2022
    Disease control and prevention
    Climate change poses pandemic threat by accelerating animal virus spread, study warns

    Hotspots for viral transmission among animals are projected to overlap with densely populated urban areas

  • Thursday, 28 April, 2022
    Special Report
    The Americas’ Fastest Growing Companies

    The FT’s third annual ranking of the region’s businesses by revenue growth rate. Plus: US medtech takes the top spot; Calgary tech scene rivals energy sector; ecommerce giant aims to ‘democratise finance’; why LatAm risks squandering pandemic gains

  • Thursday, 28 April, 2022
    Special ReportThe Americas’ Fastest Growing Companies
    Axonics takes top spot on FT ranking of high-growth businesses

    The medtech muscles in on overactive bladder market with its neuro-stimulator treatment device

  • Wednesday, 27 April, 2022
    Coronavirus pandemic
    UK government’s Covid care home policies were unlawful, High Court rules

    Discharging hospital patients into population of vulnerable elderly without testing was ‘irrational’, say judges

  • Tuesday, 26 April, 2022
    Disease control and prevention
    Global health officials probe unexplained child hepatitis cases

    The mystery illness has been recorded in the US, Israel and 10 EU countries

  • Tuesday, 26 April, 2022
    Coronavirus pandemic
    China’s Covid booster campaign slows as staff redirected to mass testing

    Almost 20mn Beijing residents will have to undergo 3 rounds of tests by Saturday

  • Monday, 25 April, 2022
    Coronavirus pandemic
    Beijing gripped by panic buying as Covid cases rise

    Supermarket shelves emptied after city officials order lockdown in several neighbourhoods

  • Monday, 25 April, 2022
    News in-depthCoronavirus pandemic
    China Covid-19 tsar pushed treatments without revealing business ties

    Renowned Beijing adviser Zhong Nanshan has links to firms behind some officially approved remedies

  • Saturday, 23 April, 2022
    Coronavirus treatment
    ‘Test to treat’ chaos is latest setback for US Covid pandemic response

    Biden’s flagship scheme giving antiviral pills to at-risk patients has run into multiple problems

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In